North American catheters market is expected to grow at a CAGR of around 8.2% during the forecast period. The major factors encouraging the growth of the market in the region include the emerging demand for minimally invasive surgeries and the increasing prevalence of chronic diseases. There are several key companies operates in North America, particularly in the US, which includes Edwards Lifesciences, Abbott Laboratories, Inc., and among others. The North American market is further sub-segmented as the US and Canada. The significant prevalence of chronic diseases is primarily contributing to the demand for catheters in the region.
To Request a Sample of our Report on North American Catheters Market: https://www.omrglobal.com/request-sample/north-american-catheters-market
As per the American Heart Association, during the period, 2013 and 2016, 121.5 million American adults had some form of cardiovascular disease. Between 2014 and 2015, direct and indirect costs of total cardiovascular diseases and stroke were $351.2 billion. CVD and stroke accounted for 14% of total health expenditures in 2014-2015. This, in turn, is encouraging the demand for cardiac catheterization procedures for the diagnosis and treatment of certain CVD conditions. During the procedure, a long thin tube is placed in an artery or vein in the groin, arm or neck and threaded through the blood vessels to the heart. Certain heart disease treatments that are performed using cardiac catheterization include coronary stenting and coronary angioplasty.
(Get 15% Discount on Buying this Report)
A full Report of North American Catheters Market is Available at: https://www.omrglobal.com/industry-reports/north-american-catheters-market
North American Catheters Market Segmentation
By Product Type
· Cardiovascular Catheters
· Urological Catheters
· Intravenous Catheters
· Specialty Catheters
· Neurovascular Catheters
(This release has been published on OMR Industry Journal. OMR Industry Journal is not responsible for any content included in this release.)
